Screening colonoscopy: Has the time come?

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Although current screening with flexible sigmoidoscopy and fetal occult blood test likely reduce colon cancer mortality, it is costly and probably not as effective as one-time screening with colonoscopy for detecting and preventing cancer, as well as risk stratification for further testing and surveillance. Ideal screening would target sensitive tests at high-risk individuals. It is possible that the identification of genetic or biologic markers in the future will enable us to target screening at high-risk individuals with precision.

Original languageEnglish (US)
Pages (from-to)501-511
Number of pages11
JournalPrimary Care - Clinics in Office Practice
Volume22
Issue number3
StatePublished - 1995

Fingerprint

Colonoscopy
Sigmoidoscopy
Occult Blood
Hematologic Tests
Fetal Blood
Genetic Markers
Colonic Neoplasms
Biomarkers
Mortality
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Screening colonoscopy : Has the time come? / Lieberman, David.

In: Primary Care - Clinics in Office Practice, Vol. 22, No. 3, 1995, p. 501-511.

Research output: Contribution to journalArticle

@article{6300af94c3684fd58e20535be379608d,
title = "Screening colonoscopy: Has the time come?",
abstract = "Although current screening with flexible sigmoidoscopy and fetal occult blood test likely reduce colon cancer mortality, it is costly and probably not as effective as one-time screening with colonoscopy for detecting and preventing cancer, as well as risk stratification for further testing and surveillance. Ideal screening would target sensitive tests at high-risk individuals. It is possible that the identification of genetic or biologic markers in the future will enable us to target screening at high-risk individuals with precision.",
author = "David Lieberman",
year = "1995",
language = "English (US)",
volume = "22",
pages = "501--511",
journal = "Primary Care - Clinics in Office Practice",
issn = "0095-4543",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Screening colonoscopy

T2 - Has the time come?

AU - Lieberman, David

PY - 1995

Y1 - 1995

N2 - Although current screening with flexible sigmoidoscopy and fetal occult blood test likely reduce colon cancer mortality, it is costly and probably not as effective as one-time screening with colonoscopy for detecting and preventing cancer, as well as risk stratification for further testing and surveillance. Ideal screening would target sensitive tests at high-risk individuals. It is possible that the identification of genetic or biologic markers in the future will enable us to target screening at high-risk individuals with precision.

AB - Although current screening with flexible sigmoidoscopy and fetal occult blood test likely reduce colon cancer mortality, it is costly and probably not as effective as one-time screening with colonoscopy for detecting and preventing cancer, as well as risk stratification for further testing and surveillance. Ideal screening would target sensitive tests at high-risk individuals. It is possible that the identification of genetic or biologic markers in the future will enable us to target screening at high-risk individuals with precision.

UR - http://www.scopus.com/inward/record.url?scp=0029098960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029098960&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0029098960

VL - 22

SP - 501

EP - 511

JO - Primary Care - Clinics in Office Practice

JF - Primary Care - Clinics in Office Practice

SN - 0095-4543

IS - 3

ER -